Financial Data and Key Metrics Changes - The company reported strong quarterly earnings of $14.1 million, resulting in diluted earnings per share of $0.83, representing increases of 92% and 93% respectively over the previous quarter [12] - On a non-GAAP basis, adjusted earnings were $15.2 million or $0.89 per share, with pretax pre-provision net income excluding merger-related costs totaling $26.1 million, an increase of 13% from the prior quarter [4][13] - The tangible common equity ratio expanded to 6.77% at June 30, with a 3% increase in tangible book value during the second quarter, reaching $26.9 per share [5][18] Business Line Data and Key Metrics Changes - The company experienced robust growth in home equity loan balances, with an increase of $16.7 million in the second quarter compared to $18 million for the entire previous year [28] - Non-interest income reached $13.1 million for the second quarter, exceeding guidance provided last quarter [14] - The non-GAAP efficiency ratio improved to 55.5%, the lowest level since 2022, indicating enhanced operational efficiency [13] Market Data and Key Metrics Changes - Average deposits were down 1% on a linked quarter basis due to seasonal trends, but there has been encouraging growth as summer approaches [7] - The loan pipeline was robust at June 30, with a committed loan pipeline of $150 million, representing a 40% increase over the last quarter [18] Company Strategy and Development Direction - The company is focused on unlocking the financial potential of its combined franchise following the acquisition of Northway Financial, particularly in the New Hampshire market [4] - Strategic investments in digital and talent-focused initiatives are expected to drive revenue growth and enhance customer relationships [10] - The company is committed to expanding its treasury management services and modernizing its mobile app to attract a digitally savvy customer base [10][60] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the overall health of the loan portfolio, despite one commercial borrower filing for bankruptcy, indicating this is not a broader trend [6] - The company anticipates strong capital generation in the second half of the year, driven by the realization of synergies and sustained revenue growth [18] - Management remains optimistic about the second half of the year, citing positive momentum in commercial volume and the integration of the New Hampshire franchise [50] Other Important Information - The company successfully launched new features in its mobile app, including a digital financial literacy program, which has seen strong customer engagement [10][60] - The company is actively working with other lenders on the bankruptcy case of a borrower, with expectations for resolution later this year [6][22] Q&A Session Summary Question: What type of C&I loan was it, and did the placement on non-accrual impact net interest income? - The loan was characterized as a service company C&I loan, and it did impact net interest income by about one basis point of net interest margin for the quarter [22][23] Question: What are the drivers of the improvement in the loan pipeline and the coupon on new originations? - The company is seeing a broad-based pickup in commercial and home equity loans, with a robust loan pipeline indicating strong demand [28][29] Question: Can you provide guidance on fee income for the next quarter? - The company estimates non-interest income for the third quarter to be in the range of $12 million to $13 million, with some caution due to fair value accounting impacts [41][44] Question: What is the overall exposure to syndicated loans? - The total exposure to the loan in question is $12 million, with a total exposure of around $200 million across five or six other banks [36] Question: Will the company consider a buyback if the stock remains low? - Management indicated that they have a buyback option available and are optimistic about the company's performance in the second half of the year [50]

Company Overview - Camden National Corporation has \$7 billion in assets, \$5 billion in loans, and \$56 billion in deposits [7] - The company has over 700 employees and 73 branches [7] - The company's market capitalization is \$739 million [7] Acquisition of Northway Financial - Camden National Corporation completed its acquisition of Northway Financial, Inc on January 2, 2025 [18] - The purchase price was \$965 million, based on Camden National's closing stock price of \$4225 on January 2, 2025 [20] - The merger is expected to result in 20% GAAP EPS accretion in 2025 and 33% in 2026 [19] Loan and Deposit Portfolio - The loan portfolio is well-diversified, with 43% in residential real estate, 42% in commercial real estate, 9% in commercial loans, and 6% in home equity and consumer loans [28] - Total loans amount to \$41 billion [28] - The company's deposits total \$46 billion, with 33% in savings/money market accounts, 32% in interest-checking accounts, 20% in noninterest-checking accounts, 11% in CDs, and 4% in brokered deposits [45] Financial Performance - Net income for the fourth quarter of 2024 was \$147 million, a 12% increase compared to the third quarter of 2024 [69] - Non-interest income is 25% of total revenue [50] - Assets Under Management (AUM) reached \$21 billion, up 12% year-over-year [50]

Financial Data and Key Metrics Changes - System wide sales for Q1 2025 were $132.6 million, up 5% compared to Q1 2024, indicating resilience in the current economic environment [10] - Revenue from continuing operations increased by 7% to $13.1 million from $12.2 million in Q1 2024 [27] - Adjusted EBITDA from continuing operations was $46,000, a significant decrease from $425,000 in Q1 2024 [10][29] - Net loss from continuing operations was $506,000, compared to a loss of $399,000 in Q1 2024 [29] Business Line Data and Key Metrics Changes - Comp sales for all clinics open for at least 13 months were up 3% for Q1 2025 and increased to 4% in March 2025 [10][23] - Comp sales for mature clinics (open for at least 48 months) were down 2% [23] - The company refranchised two corporate clinics and opened five franchise clinics during Q1 2025, with a total of 969 clinics, of which 847 (87%) are franchise clinics [25] Market Data and Key Metrics Changes - The company is experiencing a dynamic consumer environment, with consumer sentiment affecting new patient volumes [11][43] - The company anticipates system wide sales for 2025 to be between $550 million and $570 million, compared to $530.3 million in 2024 [31] Company Strategy and Development Direction - The company aims to become a pure play franchisor, with 93% of corporate clinics under Letters of Intent (LOIs) for refranchising [12][49] - The focus is on strengthening core operations, reigniting growth, and improving profitability through dynamic revenue management and enhanced digital marketing strategies [12][18] - The company plans to launch a new marketing campaign centered around pain relief in the second half of the year [36] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the impact of economic headwinds, inflation, and consumer sentiment on operations but remains optimistic about transitioning to a franchise model [33] - The company expects to see a transformative financial impact as corporate clinics transition to franchise royalties and fees, leading to increased profitability [33] Other Important Information - The company has welcomed new executives to enhance legal strategy and patient experience [39] - The Joint has been recognized as one of the fastest-growing franchises and ranked 37th in the Franchise 500 by Entrepreneur Magazine [40] Q&A Session Summary Question: New patient ad metrics and retention trends - Management noted that new patient volumes have been affected by consumer sentiment, but retention rates remain stable [42][44] Question: Metrics on profitability and overhead reduction - Management is not ready to provide specific metrics but expects profitability to improve as G&A expenses are reduced [45][47] Question: Timeline for refranchising process completion - Management intends to exit 2025 as a pure play franchisor and hopes to accelerate the refranchising process [49] Question: Comp sales performance and strategies for mature clinics - Comp sales for mature clinics have been consistent, and operational strategies will be geared towards strengthening these clinics [80][81] Question: Dynamic pricing impact - Management is exploring various pricing models and anticipates that pricing adjustments could significantly impact total system wide sales [60][62] Question: Selling and marketing expenses normalization - Management expects selling and marketing expenses to normalize by Q3 2025 as the transition to a single marketing agency is completed [66] Question: Cost of the franchisee spring convention - The cost of the convention was lower than previous years, impacting the sales and marketing line [75][76]